- Home
- ACLS vs ATRC Comparison
ACLS vs ATRC Comparison
Compare ACLS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- ATRC
- Stock Information
- Founded
- ACLS 1995
- ATRC 2000
- Country
- ACLS United States
- ATRC United States
- Employees
- ACLS N/A
- ATRC N/A
- Industry
- ACLS Industrial Machinery/Components
- ATRC Medical/Dental Instruments
- Sector
- ACLS Technology
- ATRC Health Care
- Exchange
- ACLS Nasdaq
- ATRC Nasdaq
- Market Cap
- ACLS 1.8B
- ATRC 1.6B
- IPO Year
- ACLS 2000
- ATRC 2005
- Fundamental
- Price
- ACLS $50.96
- ATRC $34.13
- Analyst Decision
- ACLS Buy
- ATRC Strong Buy
- Analyst Count
- ACLS 7
- ATRC 10
- Target Price
- ACLS $156.00
- ATRC $48.50
- AVG Volume (30 Days)
- ACLS 633.1K
- ATRC 627.8K
- Earning Date
- ACLS 04-30-2025
- ATRC 04-30-2025
- Dividend Yield
- ACLS N/A
- ATRC N/A
- EPS Growth
- ACLS N/A
- ATRC N/A
- EPS
- ACLS 6.15
- ATRC N/A
- Revenue
- ACLS $1,017,865,000.00
- ATRC $465,307,000.00
- Revenue This Year
- ACLS N/A
- ATRC $14.60
- Revenue Next Year
- ACLS $11.97
- ATRC $12.58
- P/E Ratio
- ACLS $8.29
- ATRC N/A
- Revenue Growth
- ACLS N/A
- ATRC 16.55
- 52 Week Low
- ACLS $47.23
- ATRC $18.94
- 52 Week High
- ACLS $158.61
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- ACLS 32.57
- ATRC 46.55
- Support Level
- ACLS $47.23
- ATRC $31.02
- Resistance Level
- ACLS $58.41
- ATRC $35.63
- Average True Range (ATR)
- ACLS 1.99
- ATRC 1.71
- MACD
- ACLS -0.47
- ATRC 0.08
- Stochastic Oscillator
- ACLS 28.96
- ATRC 67.46
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.